Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3',5'-monophosphate and DNA synthesis during liver regeneration.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism*; D004247:DNA / Q000096:biosynthesis*; D003864:Depression, Chemical; D004983:Ethanolamines / Q000494:pharmacology; D006498:Hepatectomy; D008099:Liver / Q000032:analysis / Q000187:drug effects; D008115:Liver Regeneration; D008297:Male; D009570:Nitriles / Q000494:pharmacology; D009929:Organ Size; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D013237:Stereoisomerism; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000813:Anilides; D004983:Ethanolamines; D009570:Nitriles; D010647:Phenyl Ethers; D011412:Propanolamines; D011437:Propylamines; D010643:Phenoxybenzamine; D004247:DNA; D011433:Propranolol; D000242:Cyclic AMP; D010646:Phentolamine